GenFleet Therapeutics Closes Series A Financing to Advance Clinical Development of Small Molecules for Immuno-Oncology Therapeutics
November 30, 2018 (Shanghai, China) -- GenFleet Therapeutics recently announced the close of its series A financing worth 120 million yuan
